Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the alpha variant B.1.1.7 of SARS-CoV-2 which emerged in Britain in December 2020 and is thought to be roughly 50 percent more infectious and now dominant in the U.S.
One unit allows the stimulation of 2,5 x 108 cells.
Gene: | S | |
Delivery: | overnight | |
Counter Ion: | TFA | |
Protein: | Spike glycoprotein | |
UniProt Id: | P0DTC2 | |
Species: | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) | |
Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
Indication : | Covid-19, Infection, Respiratory infection |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€241.50*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Product number:
LB01944